Pfizer : PFE

All Pfizer Articles

1482 Articles

Jon C. Ogg | Jun 27, 2017 at 7:15 AM EDT

25 Great American Companies Paying High Dividends

24/7 Wall St. has conducted a review of the top dividends from America’s largest companies. There were 25 such companies…

Jon C. Ogg | Jun 22, 2017 at 12:10 PM EDT

The Top 20 S&P 500 Companies Buying Back Stock in 2017

These are the top 20 stock buybacks in dollars spent during the first quarter of 2017 of all S&P 500…

Chris Lange | Jun 12, 2017 at 8:55 AM EDT

Short Sellers Grow More Selective on Major Pharma

The May 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Paul Ausick | Jun 5, 2017 at 4:01 PM EDT

Cisco Systems, United Technologies Weigh on DJIA Monday

Cisco, United Technologies, Pfizer, and Merck led the DJIA lower Monday.

Chris Lange | May 27, 2017 at 8:40 AM EDT

Big Pharma Has Big Catalysts Coming for the Rest of 2017

A new Deutsche Bank research report focuses on the big capitalization pharmaceutical stocks and the upcoming catalysts and news flow…

Chris Lange | May 25, 2017 at 9:45 AM EDT

Major Pharma Short Interest Surges

The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | May 20, 2017 at 8:15 AM EDT

10 Stocks Analysts Want You to Sell

These are the top 10 Sell equivalent ratings seen from analysts during the week of May 15 to May 19,…

Paul Ausick | May 16, 2017 at 4:01 PM EDT

UnitedHealth, Nike Weigh on DJIA Tuesday

UnitedHealth, Nike, Pfizer, and Wal-Mart led the DJIA to a modest decline Tuesday.

Jon C. Ogg | May 16, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy, Yum Brands and More

The the top analyst upgrades, downgrades and other research calls from Tuesday include AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods,…

Paul Ausick | May 15, 2017 at 11:35 AM EDT

Top Credit Suisse Pharma Picks Ahead of Catalysts

Credit Suisse provided its outlook for several large-cap pharmaceutical stocks Monday morning. The analyst has three top picks to consider.

Trey Thoelcke | May 11, 2017 at 11:40 AM EDT

Why Big Pharma Is Not at Fault for Record Drug Spending

With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it…

Chris Lange | May 11, 2017 at 10:30 AM EDT

Why Sangamo Therapeutics Is Surging

Sangamo Therapeutics saw its shares skyrocket early on Thursday after a critical business update.

Chris Lange | May 10, 2017 at 9:00 AM EDT

Short Interest in Major Pharma Shrinks

The April 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Chris Lange | May 2, 2017 at 8:50 AM EDT

Pfizer Sinks on Mixed Q1 Earnings

Pfizer reported mixed first-quarter financial results before the markets opened on Tuesday.

1 … 40 41 42 43 44 … 99

Pfizer : PFE

All Pfizer Articles

25 Great American Companies Paying High Dividends

The Top 20 S&P 500 Companies Buying Back Stock in 2017

Short Sellers Grow More Selective on Major Pharma

Cisco Systems, United Technologies Weigh on DJIA Monday

Top Presentations to Look for at ASCO

Big Pharma Has Big Catalysts Coming for the Rest of 2017

Major Pharma Short Interest Surges

10 Stocks Analysts Want You to Sell

UnitedHealth, Nike Weigh on DJIA Tuesday

Top Analyst Upgrades and Downgrades: AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy, Yum Brands and More

Top Credit Suisse Pharma Picks Ahead of Catalysts

Why Big Pharma Is Not at Fault for Record Drug Spending

Why Sangamo Therapeutics Is Surging

Short Interest in Major Pharma Shrinks

Pfizer Sinks on Mixed Q1 Earnings

Why Google’s Record AI Spending May Signal a Turning Point

$190 Billion and Climbing: Google’s Stunning Equity Raise Signals an Even Bigger AI CapEx Surge

Can Pure Dividend Stocks Replace a $110,000 Dual-Income Household Income? Here’s What It Would Take

Can Pure Dividend Stocks Replace a $110,000 Dual-Income Household Income? Here's What It Would Take

If You Have $620,000 Saved at 67 and a $90,000 Pension Buyout Decision, Here Is the Lump Sum Math

Oil Services Are Setting Up to Do It Again, But There’s a Catch the Strait of Hormuz Trade Can’t Ignore

Why Google’s Record AI Spending May Signal a Turning Point

Pfizer : PFE

All Pfizer Articles

25 Great American Companies Paying High Dividends

The Top 20 S&P 500 Companies Buying Back Stock in 2017

Short Sellers Grow More Selective on Major Pharma

Cisco Systems, United Technologies Weigh on DJIA Monday

Top Presentations to Look for at ASCO

Big Pharma Has Big Catalysts Coming for the Rest of 2017

Major Pharma Short Interest Surges

10 Stocks Analysts Want You to Sell

UnitedHealth, Nike Weigh on DJIA Tuesday

Top Analyst Upgrades and Downgrades: AIG, Exact Sciences, MercadoLibre, Pfizer, Whole Foods, Valero Energy, Yum Brands and More

Top Credit Suisse Pharma Picks Ahead of Catalysts

Why Big Pharma Is Not at Fault for Record Drug Spending

Why Sangamo Therapeutics Is Surging

Short Interest in Major Pharma Shrinks

Pfizer Sinks on Mixed Q1 Earnings

Why Google’s Record AI Spending May Signal a Turning Point

$190 Billion and Climbing: Google’s Stunning Equity Raise Signals an Even Bigger AI CapEx Surge

Can Pure Dividend Stocks Replace a $110,000 Dual-Income Household Income? Here’s What It Would Take

Featured Reads

Can Pure Dividend Stocks Replace a $110,000 Dual-Income Household Income? Here's What It Would Take

If You Have $620,000 Saved at 67 and a $90,000 Pension Buyout Decision, Here Is the Lump Sum Math